Platinum Sponsors
Astrazeneca
AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to deliver life-changing medicines to patients. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.
- www.astrazeneca.com
- Booth no. : 1
Daiichi Sankyo
With more than 120 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.
- www.daiichisankyo.com
- Booth no. : 3
Gold Sponsors
Gilead Oncology
Gilead Oncology is creating the future of oncology. From antibody-drug conjugates to small molecules, our research and development programs and partnerships are creating possibilities for people with cancer. We’re helping to bring more life to people with cancer.
- www.global.askgileadmedical.com
- Booth no. : 16
Loxo@Lilly
Loxo@Lilly aims to create medicines that make life better for all those affected by cancer around the world. Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for people with cancer.
- www.lillyloxooncologypipeline.com
- Booth no. : 2
Menarini Stemline
Menarini Stemline is committed to making a difference in cancer patients’ lives. We invest in developing precision medicine through our pipeline of investigational drugs. Partnering with cancer experts and research institutions globally, we aim to improve our outstanding cancer to enable personalized care from early detection to precision medicine.
- www.menarinistemline.com
- Booth no. : 4
MSD
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the US and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.
- www.msd.com
- Booth no. : 13
Novartis
Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
- www.novartis.com
- Booth no. : 18
Pfizer Oncology
Pfizer Oncology is committed to advancing medicines wherever we believe we can make a difference for people living with cancer. We have an industry-leading portfolio of 24 approved cancer medicines and biosimilars across 30+ indications—and are focused on delivering breakthroughs in breast cancer, genitourinary cancer, hematology and precision medicine.
- www.pfizer.com
- Booth no. : 12 & 14
Pierre Fabre Laboratories
Pierre Fabre Laboratories is a leading French medical and beauty care company with 4 decades of experience in innovation, development, manufacturing, and commercialization in oncology. The company dedicated 80% of its R&D spendings to oncology in 2022 and has declared targeted therapies as its main R&D priority. Its commercial portfolio covers colorectal, breast, lung cancers, melanoma, hematology, pre-cancerous skin conditions.
- www.pierre-fabre.com
- Booth no. : 15
Bronze Sponsors
Exact Sciences
Exact Sciences is a leading, global cancer diagnostics company. From early detection to diagnosis and treatment guidance, the company is offering and further developing a suite of tests to enable personalized care at all stages of the disease. In early breast cancer, the Oncotype DX test is the only test validated to identify patients likely to benefit from chemotherapy.
Myriad Genetics
Myriad Genetics is a genetic testing and precision medicine company dedicated to advancing health and well-being for all. In Europe, Myriad offers genomic tests through local testing collaborations that can help personalize and improve cancer care.
- www.myriadgenetics.eu
- Booth no. 29
Veracyte
Veracyte is a global diagnostics company whose vision is to transform cancer care for patients. We empower clinicians with the insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer.
- www.veracyte.com
- Booth no. 17
Exhibitors
Agendia
Agendia is a leading provider of innovative precision oncology solutions for early-stage breast cancer. Using genomic assays like MammaPrint® and BluePrint®, they enable clinicians to quickly identify the most effective treatment plan, minimizing risks of over- and under-treatment. Agendia strives to shape the future of precision oncology and combat breast cancer effectively.
- www.agendia.com
- Booth no. 33
ANGLE
World leaders in liquid biopsy, dedicated to advancing cancer care. Our Parsortix technology has the potential to deliver profound improvements in clinical and health economic outcomes in the diagnosis and treatment of cancer.
- www.angleplc.com
- Booth no. 28
APIS Assay Technologies
APIS is leveraging systems biology, interrogating multi-OMICs biodata, and deploying innovative Clickmer® ligand binding technology, for the validation and translation of biomarker and therapeutic assets into clinical utility. APIS has expertise and capabilities in IVD development of molecular & immune-assays for ultimate product realisation as diagnostic tests, including the new APIS ESR1 Mutations Kit, and APIS Breast Cancer Subtyping Kit.
- www.apisassay.com
- Booth no. 27
Biovica
Biovica develops and commercializes blood-based biomarker assays that help oncologists monitor cancer progression. Its assay, DiviTum® TKa, measures cell proliferation by detecting the TKa biomarker in the bloodstream. The assay has demonstrated its ability to provide insight into therapy effectiveness in several clinical trials in HR+ MBC. Biovica's shares are traded on the NasdaqFirstNorth.
- www.biovica.com
- Booth no. 25
Cerca Biotech GmbH
MammaTyper® is manufactured by Cerca Biotech, a German-based diagnostic company focused on bringing innovative solutions to the oncology and women’s health market.
Cerca Biotech strives to introduce the best tests to meet clinical needs at an affordable cost, with clinical accuracy and rapid results at the core.
- www.cercabiotech.com
- Booth no. 24
Menarini Silicon Biosystems
MSB is a pioneer in the field of circulating tumor cell (CTC) analysis, and its proprietary CELLSEARCH® CTC Test is the first and only clinically validated, FDA-cleared test for detecting and counting CTCs to aid physicians in managing metastatic breast cancer patients when used in conjunction with other clinical methods of monitoring. MSB is part of the Menarini Group.
- www.siliconbiosystems.com
- Booth no. 30
REVEAL GENOMICS
REVEAL GENOMICS, S.L. is a biotechnology start-up seeking to change the way biomarkers are used in oncology. It is focused on developing innovative diagnostic tools to define the best therapeutic options for patients with cancer. The company uses pioneering techniques, sophisticated computer applications, and machine learning to reveal new cancer research data.
- www.reveal-genomics.com
- Booth no. 32
SamanTree Medical
SamanTree Medical has developed a breakthrough medical imaging modality that enables new medical procedures with the will to improve cancer treatment. The Histolog® Scanner provides high resolution imaging of the surface of fresh tissue. Based on a novel ultra-fast confocal microscopy technology invented in EPFL in 2010, it finds its application along the patient journey, from biopsy to surgical diagnostics.
- www.samantree.com
- Booth no. 22
Societies
ABC Global Alliance
The ABC Global Alliance is a nonprofit association registered in Portugal, serving as a multi-stakeholder platform for those interested in collaborating on projects related to Advanced Breast Cancer worldwide. Comprising individuals and organizations, we are committed to developing, promoting, and supporting tangible improvements that create awareness and actions to enhance the lives of ABC patients globally.
- www.abcglobalalliance.org
- Booth no. 20
ESMO
ESMO is the European Society for Medical Oncology. Representing more than 35,000 oncology professionals in 172 countries, ESMO is a reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE.
- www.esmo.org
- Booth no. 19
GBG Forschungs GmbH (GBG)
GBG Forschungs GmbH (GBG) represents a professional institute of academic breast cancer research and is dedicated to continuously improving the treatment of breast cancer patients. GBG as the largest German breast cancer study group can build on > 20y of scientific experience gained from > 119 clinical trials and enrolling over 67,000 patients. Healing through innovation, competence and partnership.
- www.gbg.de
- Booth no. 23
SOLTI
SOLTI is a leading cooperative group in clinical cancer research. With a consolidated experience of more than 25 years, 80 clinical trials (30 in progress) and a network of 480 researchers in Spain, Portugal and Ireland, its main activity focuses on the design and execution of translational clinical studies mainly focused on breast cancer.
- www.gruposolti.org
- Booth no. 26
UT Health - AACR San Antonio Breast Cancer Symposium
UT Health San Antonio and the American Association for Cancer Research (AACR) are organizers of the San Antonio Breast Cancer Symposium (SABCS), December 10-14, 2024. Each year, SABCS features the latest information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant disease to an international audience of academic and private physicians and researchers.
- www.sabcs.org
- Booth no. 21
